| Air date: | Wednesday, December 16, 2015, 4:15:00 PM Time displayed is Eastern Time, Washington DC Local |
| iCalendar: |  Add an upcoming event to your calendar. |
| Description: | Dr. Grimes received his Ph.D. in Molecular Pathology and Immunology studying gene regulation with Maureen Goodenow at the University of Florida, then joined Philip Tsichlis at Fox Chase Cancer Center, cloning novel genes activated by insertion mutagenesis (e.g. Akt, Tpl2). He has a broad background in hematopoiesis, molecular biology, and molecular oncology including modeling of hematopoiesis, myelopoiesis and leukemia. His work on the Growth factor independent-1 (Gfi1) transcriptional repressor protein has spanned the initial identification of Gfi1 in a model of leukemia and the role of Gfi1 in normal myeloid biology, to the identification of GFI1 mutations in patients with severe congenital neutropenia (SCN) and non-immune chronic idiopathic neutropenia of adults (NI-CINA). His work bridges normal hematopoietic development and innate immune action with marrow failure and transformation. His lab does it all! Don’t miss this talk by a dynamic speaker! |
| Author: | H. Leighton Grimes, Ph.D.; Professor, Division of Immunobiology, Cincinnati Childrens Hospital Medical Center |
| Runtime: | 1 hour |
You will be able to view the event at http://videocast.nih.gov when the event is live.
Related Posts
| Air date: | Wednesday, December 16, 2015, 4:15:00 PM Time displayed is Eastern Time, Washington DC Local |
| iCalendar: | Add an upcoming event to your calendar. |
| Description: | Dr. Grimes received his Ph.D. in Molecular Pathology and Immunology studying gene regulation with Maureen Goodenow at the University of Florida, then joined Philip Tsichlis at Fox Chase Cancer Center, cloning novel genes activated by insertion mutagenesis (e.g. Akt, Tpl2). He has a broad background in hematopoiesis, molecular biology, and molecular oncology including modeling of hematopoiesis, myelopoiesis and leukemia. His work on the Growth factor independent-1 (Gfi1) transcriptional repressor protein has spanned the initial identification of Gfi1 in a model of leukemia and the role of Gfi1 in normal myeloid biology, to the identification of GFI1 mutations in patients with severe congenital neutropenia (SCN) and non-immune chronic idiopathic neutropenia of adults (NI-CINA). His work bridges normal hematopoietic development and innate immune action with marrow failure and transformation. His lab does it all! Don’t miss this talk by a dynamic speaker! |
| Author: | H. Leighton Grimes, Ph.D.; Professor, Division of Immunobiology, Cincinnati Childrens Hospital Medical Center |
| Runtime: | 1 hour |
You will be able to view the event at http://videocast.nih.gov when the event is live.
Related Posts
Recent Posts
New method allows scientists to follow gene activity over time in the same cells
Single-cell and single-embryo RNA sequencing
RNA sequencing reveals functional chimeric mRNAs in mammalian immunity
Deep learning improves microRNA target prediction from sequence
New Johns Hopkins Study Identifies Pervasive RT-qPCR Artifact in CRISPR Knockdown Studies and How UltraMarathonRT® Solves It
Atlas of the brain’s striatum could guide researchers to new drug treatments
RNA-Seq Products & Services
Stay Connected